Request Trial
shutterstock_1932588389_marvent
marvent / Shutterstock.com
15 November 2022FeaturesBiotechnologyJanine Swarbrick and Sofie McPherson

Promoting women in STEM

Historically, professions in science and law have been dominated by men, but how does this industry look in 2022? Are women really at the heart of it? Why should they be there? And what more could be done to support women in their careers in this field?

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Biotechnology
Merck KGaA agrees $11.3bn deal in major life sciences expansion
26 June 2026   Deal is aimed at strengthening German company’s presence across high-growth life sciences markets by adding a portfolio of advanced research and analytical technologies.
Biotechnology
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026   Novartis will work with a US biotech company on new cancer therapies, while Lilly has partnered with a Chinese biopharma firm to develop new medicines.
Biotechnology
Insilico lands potential $2.5bn AI biotech partnership
22 June 2026   The partnership, announced at BIO 2026, marks the largest Asia-Pacific partnership by potential value that the AI-driven drug discovery company has secured to date.


Editor's picks

What’s at stake in Australia’s biggest pharma patent appeal in years?
Big Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026

Editor's picks

Big Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026
Biotechnology
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026
Biotechnology
Insilico lands potential $2.5bn AI biotech partnership
22 June 2026
Big Pharma
US life sciences damages averaged $33.5m between 2019-2025
18 June 2026
Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026
Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026

More features

Ashurst Perkins Coie opens its doors following landmark merger
Merck KGaA agrees $11.3bn deal in major life sciences expansion
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
Insilico lands potential $2.5bn AI biotech partnership
US life sciences damages averaged $33.5m between 2019-2025
Court upholds $83m sequencing verdict and sets royalty rate
Exclusive: ‘Cultural differences are an asset’ at the UPC
Amgen and subsidiary dealt $20m blow over rodent antibody tech